Get the Stockscreener App
3.11
0.32%
-0.01
After Hours:
3.01
-0.10
-3.22%
Evaxion Biotech A S Adr Stock (EVAX) Forecast
The Evaxion Biotech A S Adr (EVAX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $18.86, representing a +506.33% increase from the current price of $3.11. The highest analyst price target is $17.50, and the lowest is $20.22.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EVAX Price Target
Average 90.50
(+2,810% Upside)
Is Evaxion Biotech A S Adr (EVAX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 51.29 | Neutral |
| STOCH(9,6) | 37.11 | Neutral |
| STOCHRSI(14) | 77.93 | Neutral |
| MACD(12,26) | -0.00838 | Sell |
| ADX(14) | 22.36 | Neutral |
| William %R | -50.13 | Neutral |
| CCI(14) | 1.933 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.033
Buy
|
3.0564
Buy
|
| MA20 |
3.1235
Sell
|
3.0705
Buy
|
| MA50 |
2.9889
Buy
|
3.0798
Buy
|
| MA100 |
3.1543
Sell
|
3.3304
Sell
|
| MA200 |
3.9839
Sell
|
4.5803
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, EVAX could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on EVAX, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 51.29 indicates that EVAX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 37.11 indicates that EVAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 77.93 indicates that EVAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.36 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 1.933 indicates that EVAX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term EVAX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Evaxion Biotech A S Adr financial reports and earnings history, Evaxion Biotech A S Adr (EVAX) stock could reach $61.00 by 2030, $287.08 by 2040 and $37.37 by 2050. See the projected annual prices until 2050 of the Evaxion Biotech A S Adr stock below:
- Evaxion Biotech A S Adr (EVAX) is expected to reach an average price of $27.89 in 2035, with a high prediction of $29.24 and a low estimate of $28.26. This indicates an $796.69% rise from the last recorded price of $3.11.
- Evaxion Biotech A S Adr (EVAX) stock is projected to chart a bullish course in 2040, with an average price target of $282.10, representing an $8,971% surge from its current level. The forecast ranges from a conservative $282.70 to a sky-high $287.08.
- Our analysts predict Evaxion Biotech A S Adr (EVAX) to jump 6,130% by 2045, soaring from $194.36 to an average price of $193.76, potentially reaching $197.52. While $194.36 is the low estimate, the potential upside is significant.
- Evaxion Biotech A S Adr (EVAX) stock is expected to climb by 2050, reaching an average of $28.17, a $805.79% jump from its current level. However, a wide range of estimates exists, with high and low targets of $37.37 and $28.28, respectively, highlighting the market's uncertainty.
Evaxion Biotech A S Adr Stock (EVAX) Year by Year Forecast
Evaxion Biotech A S Adr Stock (EVAX) Price Forecast for 2024
Our forecast for EVAX stock price in 2024 now indicates an average price target of $12.50 with a high forecast of $23.14 and a low forecast of $1.8656. The average prediction reflects an increase of +301.94% from the last recorded price of $3.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2024 | $20.48 | $20.22 | $17.50 | +558.53% |
| December, 2024 | $19.67 | $1.8656 | $22.57 | +532.56% |
Evaxion Biotech A S Adr Stock (EVAX) Price Forecast for 2025
Evaxion Biotech A S Adr Stock (EVAX) is expected to reach an average price of $90.50 in 2025, with a high prediction of $180.92 and a low estimate of $0.0788. This indicates an +2,810% rise from the last recorded price of $3.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $14.46 | $2.2109 | $27.89 | +365.08% |
| February, 2025 | $0.7171 | $0.0788 | $180.92 | -76.94% |
| March, 2025 | $21.13 | $9.0447 | $19.23 | +579.42% |
| April, 2025 | $21.34 | $24.43 | $21.42 | +586.13% |
| May, 2025 | $33.59 | $22.30 | $27.39 | +979.92% |
| June, 2025 | $31.93 | $32.73 | $31.25 | +926.77% |
| July, 2025 | $30.94 | $32.16 | $30.76 | +894.89% |
| August, 2025 | $28.59 | $28.96 | $28.03 | +819.23% |
| September, 2025 | $28.64 | $29.77 | $26.94 | +820.74% |
| October, 2025 | $35.64 | $35.68 | $35.96 | +1,046% |
| November, 2025 | $33.19 | $34.29 | $34.27 | +967.22% |
| December, 2025 | $19.60 | $25.70 | $31.95 | +530.20% |
Evaxion Biotech A S Adr Stock (EVAX) Price Forecast for 2026
The predicted value for Evaxion Biotech A S Adr (EVAX) in 2026 is set at an average of $19.13. Estimates vary from a peak of $24.17 to a trough of $14.09, indicating an +515.05% surge from the present price of $3.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $23.75 | $21.17 | $18.88 | +663.55% |
| February, 2026 | $26.09 | $26.69 | $24.17 | +739.01% |
| March, 2026 | $15.74 | $18.94 | $16.62 | +406.12% |
| April, 2026 | $19.45 | $16.60 | $18.25 | +525.37% |
| May, 2026 | $18.80 | $19.60 | $18.67 | +504.37% |
| June, 2026 | $21.49 | $21.56 | $20.68 | +591.09% |
| July, 2026 | $20.95 | $21.45 | $21.67 | +573.68% |
| August, 2026 | $20.00 | $20.50 | $19.20 | +543.04% |
| September, 2026 | $20.71 | $20.06 | $21.95 | +565.82% |
| October, 2026 | $16.55 | $18.25 | $20.17 | +432.28% |
| November, 2026 | $12.20 | $14.59 | $16.58 | +292.31% |
| December, 2026 | $14.31 | $14.09 | $13.81 | +360.12% |
Evaxion Biotech A S Adr Stock (EVAX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Evaxion Biotech A S Adr (EVAX) is $7.0412, with a high forecast of $13.52 and a low forecast of $0.5609. This indicates an +126.40% increase from the last price of $3.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $13.06 | $13.36 | $13.52 | +319.83% |
| February, 2027 | $12.00 | $12.14 | $12.12 | +285.97% |
| March, 2027 | $13.60 | $13.71 | $13.11 | +337.34% |
| April, 2027 | $11.63 | $13.16 | $12.83 | +273.93% |
| May, 2027 | $10.21 | $10.84 | $10.72 | +228.17% |
| June, 2027 | $7.4158 | $7.3296 | $8.5931 | +138.45% |
| July, 2027 | $7.6618 | $7.4183 | $7.2628 | +146.36% |
| August, 2027 | $4.5187 | $5.6717 | $6.7235 | +45.30% |
| September, 2027 | $6.2974 | $5.5705 | $5.5774 | +102.49% |
| October, 2027 | $5.1744 | $5.1827 | $5.1392 | +66.38% |
| November, 2027 | $3.6113 | $3.9113 | $4.5511 | +16.12% |
| December, 2027 | $0.45 | $0.5609 | $2.174 | -85.53% |
Evaxion Biotech A S Adr Stock (EVAX) Price Forecast for 2028
In 2028, Evaxion Biotech A S Adr (EVAX) is projected to reach an average price of $55.85, with a high projection of $111.43 and a low estimate of $0.2717. This indicates an +1,696% rise from the last price of $3.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $104.23 | $0.2717 | $87.95 | +3,251% |
| February, 2028 | $110.22 | $98.50 | $95.15 | +3,444% |
| March, 2028 | $96.84 | $105.24 | $107.96 | +3,014% |
| April, 2028 | $94.03 | $96.76 | $95.85 | +2,924% |
| May, 2028 | $85.75 | $95.38 | $89.23 | +2,657% |
| June, 2028 | $98.74 | $84.39 | $88.74 | +3,075% |
| July, 2028 | $93.14 | $95.84 | $93.99 | +2,895% |
| August, 2028 | $53.75 | $64.85 | $90.36 | +1,628% |
| September, 2028 | $51.14 | $53.10 | $50.18 | +1,544% |
| October, 2028 | $64.64 | $60.47 | $57.72 | +1,979% |
| November, 2028 | $88.86 | $78.09 | $111.43 | +2,757% |
| December, 2028 | $90.45 | $92.85 | $87.83 | +2,808% |
Evaxion Biotech A S Adr Stock (EVAX) Price Forecast for 2029
The 2029 price forecast for Evaxion Biotech A S Adr Stock (EVAX) is $77.85 on average, with a high prediction of $94.59 and a low estimate of $61.10. This represents an +2,403% increase from the previous price of $3.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $97.37 | $87.40 | $91.17 | +3,031% |
| February, 2029 | $93.96 | $94.76 | $94.59 | +2,921% |
| March, 2029 | $93.16 | $93.31 | $91.91 | +2,895% |
| April, 2029 | $86.75 | $87.55 | $89.88 | +2,689% |
| May, 2029 | $84.97 | $86.55 | $84.98 | +2,632% |
| June, 2029 | $89.56 | $90.26 | $91.42 | +2,780% |
| July, 2029 | $86.96 | $88.96 | $88.29 | +2,696% |
| August, 2029 | $75.48 | $77.58 | $84.43 | +2,327% |
| September, 2029 | $69.17 | $70.06 | $68.60 | +2,124% |
| October, 2029 | $72.79 | $72.39 | $71.74 | +2,240% |
| November, 2029 | $60.68 | $63.88 | $62.43 | +1,851% |
| December, 2029 | $62.07 | $61.10 | $60.35 | +1,896% |
Evaxion Biotech A S Adr Stock (EVAX) Price Forecast for 2030
Evaxion Biotech A S Adr Stock (EVAX) is expected to reach an average price of $48.16 in 2030, with a high forecast of $61.00 and a low forecast of $35.33. This signifies an +1,449% surge from the last price of $3.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $59.79 | $60.59 | $61.00 | +1,823% |
| February, 2030 | $60.74 | $61.58 | $60.36 | +1,853% |
| March, 2030 | $58.88 | $59.88 | $60.03 | +1,793% |
| April, 2030 | $55.79 | $56.42 | $57.60 | +1,694% |
| May, 2030 | $56.79 | $54.92 | $55.49 | +1,726% |
| June, 2030 | $47.98 | $52.68 | $52.84 | +1,443% |
| July, 2030 | $41.80 | $44.19 | $47.06 | +1,244% |
| August, 2030 | $42.70 | $42.37 | $41.15 | +1,273% |
| September, 2030 | $39.29 | $40.09 | $41.22 | +1,163% |
| October, 2030 | $35.91 | $36.31 | $37.77 | +1,055% |
| November, 2030 | $36.00 | $36.48 | $35.38 | +1,058% |
| December, 2030 | $33.12 | $35.33 | $34.82 | +965.11% |
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):